From Karolinska Institutet and Karolinska University Hospital, Stockholm, Uppsala University, Uppsala, and AnOpIVA, Karlstad, Sweden; Statens Serum Institut and Copenhagen University Hospital, Copenhagen, Aalborg University Hospital, Aalborg, and Næstved Hospital, Næstved, Denmark; and Drexel University, Philadelphia, Pennsylvania.
Ann Intern Med. 2017 Feb 21;166(4):248-256. doi: 10.7326/M16-1415. Epub 2016 Dec 20.
Possible negative effects, including increased mortality, among persons who receive stored red blood cells (RBCs) have recently garnered considerable attention. Despite many studies, including 4 randomized trials, no consensus exists.
To study the association between the length of RBC storage and mortality in a large population-based cohort of patients who received transfusions, allowing detection of small yet clinically significant effects.
Binational cohort study.
All transfusion recipients in Sweden and Denmark.
854 862 adult patients who received transfusions from 2003 to 2012.
Patients were followed from first blood transfusion. Relative and absolute risks for death in 30 days or 1 year in relation to length of RBC storage were assessed by using 3 independent analytic approaches. All analyses were conducted by using Cox proportional hazards regression.
Regardless of the analytic approach, no association was found between the length of RBC storage and mortality. The difference in 30-day cumulative mortality between patients receiving blood stored for 30 to 42 days and those receiving blood stored for 10 to 19 days was -0.2% (95% CI, -0.5% to 0.1%). Even among patients who received more than 6 units of RBCs stored for 30 days or longer, the hazard ratio of death was 1.00 (CI, 0.96 to 1.05) compared with those who received no such units.
Observational study; risk of confounding by indication.
Consistent with previous randomized trials, this study found no association between the length of storage of transfused RBCs and patient mortality. Results were homogeneous, with differences in absolute mortality consistently less than 1% among the most extreme exposure categories. These findings suggest that the current practice of storing RBCs for up to 42 days does not need to be changed.
The Swedish Research Council, Swedish Heart-Lung Foundation, Swedish Society for Medical Research, Strategic Research Program in Epidemiology at Karolinska Institutet, and Danish Council for Independent Research.
最近,人们对输注贮存的红细胞(RBC)的患者可能出现的负面效应,包括死亡率增加,给予了相当大的关注。尽管进行了许多研究,包括 4 项随机试验,但仍未达成共识。
在接受输血的大型基于人群的患者队列中,研究 RBC 储存时间与死亡率之间的关联,以便检测到微小但具有临床意义的影响。
两国队列研究。
瑞典和丹麦的所有输血接受者。
2003 年至 2012 年期间接受输血的 854862 名成年患者。
患者从首次输血开始接受随访。通过使用 3 种独立的分析方法,评估 30 天或 1 年内死亡的相对和绝对风险与 RBC 储存时间的关系。所有分析均通过 Cox 比例风险回归进行。
无论采用哪种分析方法,均未发现 RBC 储存时间与死亡率之间存在关联。接受储存 30 至 42 天的血液的患者与接受储存 10 至 19 天的血液的患者之间 30 天累积死亡率差异为-0.2%(95%CI,-0.5%至 0.1%)。即使在接受超过 6 个单位储存 30 天或更长时间的 RBC 的患者中,死亡风险比也为 1.00(CI,0.96 至 1.05),与未接受此类单位输血的患者相比。
观察性研究;存在混杂因素的风险。
与之前的随机试验一致,本研究未发现输注 RBC 储存时间与患者死亡率之间存在关联。结果具有同质性,在最极端的暴露类别中,绝对死亡率的差异始终小于 1%。这些发现表明,目前将 RBC 储存长达 42 天的做法无需改变。
瑞典研究委员会、瑞典心肺基金会、瑞典医学研究协会、卡罗林斯卡研究所流行病学战略研究计划和丹麦独立研究理事会。